M&A Deal Summary |
|
|---|---|
| Date | 2015-12-09 |
| Target | Swiss Caps USA - Softgel Production Facility |
| Sector | Life Science |
| Buyer(s) | Marine Ingredients |
| Sellers(s) | Swiss Caps USA |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1997 |
| Sector | Life Science |
Marine Ingredients is a manufacturer of superior quality marine ingredients, with a primary focus on Omega-3 fatty acids derived from fish. Company offer a full range of fish oils including minimally processed, highly refined and molecularly distilled. All products are produced in a pharmaceutical drug-licensed, NSF and cGMP certified facility, and meet or exceed all domestic and international standards for purity and potency.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |
Swiss Caps USA Inc. is a developer, manufacturer, and marketer of vitamins, over the counter medications, and nutritional supplements.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |